Abstract
Background The COVID-19 pandemic has major ramifications for global health and the economy, with growing concerns about economic recession and implications for mental health. Here we investigated the associations between COVID-19 pandemic-related income loss with financial strain and mental health trajectories over a 1-month course.
Methods Two independent studies were conducted in the U.S and in Israel at the beginning of the outbreak (March-April 2020, T1; N = 4 171) and at a 1-month follow-up (T2; N = 1 559). Mixed-effects models were applied to assess associations among COVID-19-related income loss, financial strain, and pandemic-related worries about health, with anxiety and depression, controlling for multiple covariates including pre-COVID-19 income.
Findings In both studies, income loss and financial strain were associated with greater depressive symptoms at T1, above and beyond T1 anxiety, worries about health, and pre-COVID-19 income. Worsening of income loss was associated with exacerbation of depression at T2 in both studies. Worsening of subjective financial strain was associated with exacerbation of depression at T2 in one study (US).
Interpretation Income loss and financial strain were uniquely associated with depressive symptoms and the exacerbation of symptoms over time, above and beyond pandemic-related anxiety. Considering the painful dilemma of lockdown versus reopening, with the tradeoff between public health and economic wellbeing, our findings provide evidence that the economic impact of COVID-19 has negative implications for mental health.
Funding This study was supported by grants from the National Institute of Mental Health, the US-Israel Binational Science Foundation, Foundation Dora and Kirsh Foundation.
Competing Interest Statement
Ran Barzilay serves on the scientific board and reports stock ownership in "Taliaz Health", with no conflict of interest relevant to this work. All other authors have no conflicts of interest do declare.
Funding Statement
This study was supported by the National Institute of Mental Health (NIMH) grants K23-MH120437 (RB), R01-MH119219 (REG, RCG), R01-MH117014 (RCG), the US-Israel Binational Science Foundation Grant No. 2017369 (REG, DG and RB), Foundation Dora, Kirsh Foundation and the Lifespan Brain Institute of Childrens Hospital of Philadelphia and Penn Medicine, University of Pennsylvania. DMG was funded in part by the Zuckerman STEM Leadership Program. The funding source had no role in the study design, collection, analysis, or interpretation of data, the writing of the article, or decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Review Boards of the University of Pennsylvania and Sheba Medical Center.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data collected for this study includes individual participants data. Data cannot be publicly accessible due to Institutional Review Board guidelines. We are open to collaborations with other researchers upon contacting us.
